Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Director's Message

Director’s Messages from 2022

Suicide Prevention Research in a Rapidly Changing World

By Joshua Gordon on

In this Director’s message, Dr. Gordon discusses what we have learned about suicide risk and prevention during the COVID-19 pandemic and how NIMH has been building upon these findings to meet the needs of a rapidly changing world.

Addressing HIV-related Intersectional Stigma and Discrimination

By Joshua A. Gordon, M.D., Ph.D., and Maureen M. Goodenow, Ph.D., Associate Director for AIDS Research and Director, Office of AIDS Research, National Institutes of Health on

In this jointly written Director’s Message, Dr. Gordon and Dr. Goodenow discuss the importance of addressing intersectional stigma in the context of HIV prevention, treatment, and care.

Bringing Innovation to the Search for Biomarkers

By Joshua Gordon on

In this Director’s Message, Dr. Gordon highlights research supported by the NIMH Small Business Innovation Research program that could advance the development of clinically relevant biomarkers.

COVID-19 Risks for People with Serious Mental Illness

By Joshua Gordon on

In this Director’s Message, Dr. Gordon highlights the increased health risks associated with COVID-19 for people with serious mental illness.

Research Along the Autism Spectrum: Diverse Research to Meet Diverse Needs

By Joshua Gordon on

In this message for Autism Awareness Month, Dr. Gordon highlights the importance of a research portfolio that addresses the full spectrum of needs of individuals with autism, across the full lifespan.

Balancing the NIMH Portfolio

By Joshua Gordon on

In this Director’s message, Dr. Gordon takes a look at NIMH’s portfolio balance, to see where we have come from and where we are headed.

Steps Toward Equity at NIMH: An Update

By Joshua Gordon on

In this Director’s Message, Dr. Gordon provides an update on efforts to advance equity, promote anti-racist ideas and actions, and encourage lasting change at NIMH.